LRIG3 antibody
Quick Overview for LRIG3 antibody (ABIN7191315)
Target
See all LRIG3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Purification
- Antigen affinity purification
-
Immunogen
- Synthetic peptide of Human LRIG3
-
Isotype
- IgG
-
-
-
-
Application Notes
- ELISA:1:1000-1:5000, IHC:1:25-1:100,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
-
Alternative Name
- LRIG3
-
Background
-
Background: Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by microarray analysis among genes that show differential expression during gastrulation in Xenopus laevis. Lrig3 was expressed in the neural plate and neural crest (NC) at neurula stages, and in NC derivatives and other dorsal structures during tailbud stages. A prominent consequence of the morpholino-induced inhibition of Lrig3 expression was impaired NC formation, as revealed by the suppression of marker genes, including Slug, Sox9 and Foxd3.
Aliases: Leucine-rich repeats and immunoglobulin-like domains protein 3 antibody, Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3 antibody, LIG-3 antibody, LIG3 antibody, LRIG1-3 antibody, Lrig3 antibody, LRIG3_HUMAN antibody
-
UniProt
- Q6UXM1
Target
-